Article History
Accepted: 24 March 2021
First Online: 19 April 2021
Declarations
:
: The research to which this correspondence refers was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases.
: The NIH, but not the authors of this letter, reports the following disclosure statement: The National Institutes of Health holds patents on targeting JAKs. NIAMS and Pfizer have a Collaborative Research and Development Award (CRADA). However, the authors have no direct involvement in these patents or awards.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the writing of this letter.